Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells.

Ushijima M, Ogata Y, Tsuda H, Akagi Y, Matono K, Shirouzu K.

Oncol Rep. 2014 Jan;31(1):19-26. doi: 10.3892/or.2013.2839. Epub 2013 Nov 8.

2.

Effects of antineoplaston AS2-1 against post-operative lung metastasis in orthotopically implanted colon cancer in nude rat.

Matono K, Ogata Y, Tsuda H, Araki Y, Shirouzu K.

Oncol Rep. 2005 Mar;13(3):389-95.

PMID:
15706406
3.

Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.

Tsuda H, Iemura A, Sata M, Uchida M, Yamana K, Hara H.

Kurume Med J. 1996;43(2):137-47.

4.

Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells.

Ren JZ, Huo JR.

Med Oncol. 2012 Jun;29(2):915-8. doi: 10.1007/s12032-011-9836-9. Epub 2011 Feb 5.

PMID:
21298366
5.

The preventive effect of antineoplaston AS2-1 on HCC recurrence.

Tsuda H, Sata M, Kumabe T, Uchida M, Hara H.

Oncol Rep. 2003 Mar-Apr;10(2):391-7.

PMID:
12579278
6.

Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.

Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ.

Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30.

PMID:
20802524
7.
8.

A novel strategy for remission induction and maintenance in cancer therapy.

Tsuda H, Sata M, Ijuuin H, Kumabe T, Uchida M, Ogou Y, Akagi Y, Shirouzu K, Hara H, Nakashima Y.

Oncol Rep. 2002 Jan-Feb;9(1):65-8.

PMID:
11748457
9.

Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients.

Tsuda H, Hara H, Eriguchi N, Nishida H, Yoshida H, Kumabe T, Sugita Y.

Kurume Med J. 1995;42(4):241-9.

11.

[Growth and gene expression of leukemia cell after treated with methylation inhibitor 5-aza-2'-deoxycytidine].

Qiao SK, Xu SR, Guo XN.

Zhonghua Xue Ye Xue Za Zhi. 2004 Aug;25(8):486-90. Chinese.

PMID:
15555266
12.

[Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].

Wang R, Li LW, Wang RL, Fan QX, Zhao PR, Wang LX, Lu SH.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):894-7. Chinese.

PMID:
17533738
13.

Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds.

Berner C, Aumüller E, Gnauck A, Nestelberger M, Just A, Haslberger AG.

Ann Nutr Metab. 2010;57(3-4):183-9. doi: 10.1159/000321514. Epub 2010 Nov 18.

PMID:
21088384
14.

Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.

Habano W, Gamo T, Terashima J, Sugai T, Otsuka K, Wakabayashi G, Ozawa S.

BMC Cancer. 2011 Feb 22;11:81. doi: 10.1186/1471-2407-11-81.

15.
16.

Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells.

Moon JW, Lee SK, Lee JO, Kim JH, Kim N, Kim J, Kim HS, Park SH.

Anticancer Res. 2014 Jan;34(1):133-40.

PMID:
24403453
18.

All-trans retinoic acid activates E-cadherin expression via promoter hypomethylation in the human colon carcinoma HCT116 cells.

Woo YJ, Jang KL.

Biochem Biophys Res Commun. 2012 Sep 7;425(4):944-9. doi: 10.1016/j.bbrc.2012.08.038. Epub 2012 Aug 15.

PMID:
22910408
19.

[As2O3 induces demethylation and up-regulates transcription of SHP-1 gene in human lymphoma cell line T2 cells].

Yang L, Luo JM, Li Y, Liu XJ, Wen SP, Du XY, Yao L, Yang JC, Dong ZR.

Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):423-7. Chinese.

PMID:
19950550
20.

Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).

Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W.

Bioorg Med Chem. 2009 Apr 15;17(8):3053-60. doi: 10.1016/j.bmc.2009.02.063. Epub 2009 Mar 6.

PMID:
19329328

Supplemental Content

Support Center